1-(4-Bromophenyl)-4,5-diphenyl-2-(1 <i>H</i> -pyrrol-2-yl)-1 <i>H</i> -imidazole
The title compound, C<sub>25</sub>H<sub>18</sub>BrN<sub>3</sub>, crystallizes in the triclinic <i>P</i>1 space group. It is of inter-est with respect to anti-cancer activity, anti-biotic, anti-bacterial and anti-fungal properties. The extended structure features N-H⋯N, C-H⋯N, C-H⋯π, N-H⋯π, C-H⋯Br and C-Br⋯π inter-actions.
Authors
- Seeralan Nagaraj
- Nagarajan Loganathan
Institutions
- University Grants Commission (IN)
- Bharathidasan University (IN)
Publication Details
- Journal
- IUCrData
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1107/s2414314626001070
- Primary Topic
- Crystal structures of chemical compounds
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Science and Engineering Research Board
- Rashtriya Uchchatar Shiksha Abhiyan